Biotech China 2014
Cardiovascular Research Technologies (CRT) 2013 Valve and Structural Heart Revolution IV


Washington, District of Columbia
http://www.crtmeeting.org/default.aspx
Cardiovascular Research Technologies (CRT) 2013 will take place 
from February 23 - 26, 2013 in Washington DC. This year’s conference 
will be the most comprehensive to date. CRT 2013 has many 
new and exciting features, including a new, cutting-edge Valve & Structural 
Heart track, in addition to its standard five subject areas -- Coronary, Endovascular, Science, Technology and Nurse & Tech. 
Also new this year will be the Essentials of Clinical Research course as well as more exciting hands-on workshops and simulations.

Schedule of Presentations:

Tuesday, February 26, 2013
08:00:00 Valve and Structural Heart Revolution IV | Direct Flow Medical: Experience with a Conformable, Repositionable, Retrievable Percutaneous Aortic Valve Reginald I. Low
08:00:00 Valve and Structural Heart Revolution IV | SECOND GENERATION VALVE PROGRAMS Hans R. Figulla
08:10:00 Valve and Structural Heart Revolution IV | The Lotus Device: Design and First-in-Man Experiences with a Repositionable, Self-Expanding Percutaneous Aortic Valve Ian T. Meredith
08:20:00 Valve and Structural Heart Revolution IV | Engager Valve Program
08:30:00 Valve and Structural Heart Revolution IV | JenaValve’s Aortic Clip Concept for Aortic Valve Hans R. Figulla
08:40:00 Valve and Structural Heart Revolution IV | Portico: The St. Jude Self Expanding Aortic Valve
08:50:00 Valve and Structural Heart Revolution IV | Is Aortic Insufficiency the Next THV Target? Proposed Technology Solutions Stanton Rowe
09:00:00 Valve and Structural Heart Revolution IV | Panel Discussion: What Should Be the Optimal Design for Percutaneous Aortic Valve Therapy? Zachary M. Gertz, Hans R. Figulla, Reginald I. Low, Stanton Rowe, Keith D. Dawkins, Raoul Bonan
09:20:00 Valve and Structural Heart Revolution IV | Break
09:40:00 Valve and Structural Heart Revolution IV | Cerclage Annuloplasty for Mitral Valve Regurgitation Robert J. Lederman
09:50:00 Valve and Structural Heart Revolution IV | Direct Annuloplasty with QuantumCor: Device Evolution, Technique and Clinical Update Richard R. Heuser
10:00:00 Valve and Structural Heart Revolution IV | The Occlutech LAA-Occluder Concept Hans R. Figulla
10:10:00 Valve and Structural Heart Revolution IV | The Carillon: Device Iteration, New Data, and New Trials
10:20:00 Valve and Structural Heart Revolution IV | Development of a Novel Valvuloplasty Scoring Balloon for the Treatment of Critical Aortic Valve Stenosis: Design of an FIM Study Gary Gershony
10:30:00 Valve and Structural Heart Revolution IV | Mitralign Program Update Lutz Buellesfeld
10:40:00 Valve and Structural Heart Revolution IV | Pulmonic Valves Replacement Ziyad M. Hijazi
10:45:00 Valve and Structural Heart Revolution IV | PFO LAA OCCLUDERS Lutz Buellesfeld, Ziyad M. Hijazi
10:50:00 Valve and Structural Heart Revolution IV | The Occlutech Innovations: ASD,PFO, LAA Occluders, Aortic Enlarger Preventer Hans R. Figulla
11:00:00 Valve and Structural Heart Revolution IV | The PROTECT and PREVAIL Trials: How Are they Different? David R. Holmes
11:10:00 Valve and Structural Heart Revolution IV | Parade of Devices for LAA Closure
11:20:00 Valve and Structural Heart Revolution IV | The Spectrum of Late Complications of LAA- Closure: Device-Specific Mechanisms, Incidence, and Prevention Peter C. Block
11:30:00 Valve and Structural Heart Revolution IV | A Primer of LAA Closure Imaging: Essential Views and Pattern Recognition Steven A Goldstein
11:40:00 Valve and Structural Heart Revolution IV | Tips and Tricks for LAA Closure Saibal Kar
11:50:00 Valve and Structural Heart Revolution IV | PFO and ASD Closure Technical Aspects Ziyad M. Hijazi
12:00:00 Valve and Structural Heart Revolution IV | The World After RESPECT and PC Trials: The Swiss Perspective Lutz Buellesfeld
12:10:00 Valve and Structural Heart Revolution IV | PFO Closure: Review of the Trials for Migraine
12:20:00 Valve and Structural Heart Revolution IV | Percutaneous VAD for End-Stage Heart Failure Daniel Burkhoff
12:30:00 Valve and Structural Heart Revolution IV | LUNCH SYMPOSIUM WITH INDUSTRY AND ACADEMIA - SHOULD WE RECALL THE APPROPRIATENESS USE CRITERIA
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.